Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Luminex Corporation

QualityClass II recall11 Nov 2026

Luminex Corporation

11 Nov 2026: Class II recall · LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303. Recorded in the openFDA device enforcement reports.

View the source record

Reported
11 Nov 2026
Recall Class
Class II
Product
LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303
Reason
Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection.
Country
United States
Status
Ongoing
Reference
Z-0359-2027
Location
Northbrook, IL
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Luminex Corporation

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.